Tracking every rollback, reversal, and overreach — and the path back to the America we know.
Executive Order 14217 directs the reduction and streamlining of federal agencies and bureaucratic operations. The order aims to decrease the size and scope of federal government through workforce reductions and agency consolidation. The direct impact on Americans includes potential changes to federal services, employment, and government spending.
Executive Order 14219 establishes the Department of Government Efficiency to streamline federal regulations and reduce government oversight. The order directs federal agencies to eliminate regulations deemed unnecessary or burdensome. This could impact Americans by reducing regulatory protections in areas including environmental standards, worker safety, and consumer protections.
On February 14, 2025, President Trump signed Executive Order 14213 establishing the National Energy Dominance Council. The order creates a new council structure within the executive branch to coordinate energy policy and domestic energy production. The confirmed direct impact includes the creation of a new federal council tasked with energy policy coordination, though specific operational changes and effects on Americans remain to be implemented.
On February 13, 2025, President Trump signed Memorandum 2025-02872 directing the implementation of reciprocal tariffs based on countries' tariff rates against U.S. goods. The memorandum instructs the U.S. Trade Representative to analyze tariff structures and recommend reciprocal duty rates. Americans importing goods, purchasing foreign products, and consumers face potential price increases pending tariff implementation details.
The Senate confirmed Kevin Warsh as Chair of the Federal Reserve, replacing Jerome Powell. Warsh, a former Fed governor and Trump ally, takes leadership of the central bank during economic uncertainty. This appointment gives Trump direct influence over monetary policy, interest rates, and banking regulation affecting all Americans.
Executive Order 14210 was signed on February 11, 2025, implementing a workforce optimization initiative under the Department of Government Efficiency. The order directs federal agencies to reduce headcount and streamline operations according to efficiency metrics established by the initiative. Confirmed direct impacts include federal employee furloughs, hiring freezes at multiple agencies, and reduced staffing in federal departments responsible for benefits processing, permitting, and regulatory functions.
On February 10, 2025, President Trump signed Executive Order 14207 eliminating the Federal Executive Institute, a leadership training program for federal executives. The order directs the closure of the institute and discontinuation of its executive development programs. The confirmed direct impact is the termination of professional development training previously available to federal managers and senior civil servants.
On February 10, 2025, President Trump signed Proclamation 2025-02833 adjusting imports of steel into the United States. The proclamation modifies tariff rates on steel products entering the country. The confirmed direct impact includes changed pricing and availability of steel for American manufacturers, construction projects, and consumers purchasing steel-containing goods.
On February 10, 2025, Executive Order 14209 was signed directing a pause in enforcement of the Foreign Corrupt Practices Act (FCPA). The order suspends active FCPA investigations and enforcement actions by the Department of Justice and Securities and Exchange Commission. The direct effect is that ongoing cases against American companies and individuals for foreign bribery have been halted pending review.
Executive Order 14200 was signed on February 5, 2025, amending duties and enforcement mechanisms related to synthetic opioid supply chains from China. The order modifies existing tariff and import protocols for substances and precursors identified as contributors to opioid trafficking. The confirmed direct impact includes changes to customs enforcement procedures and potential alterations to import costs for pharmaceutical and chemical manufacturers sourcing from China.